OncoDaily (P53 Inc.) has appointed Jo Sawyer as Vice President of Strategic Partnerships and Industry Relations. The appointment strengthens its executive leadership as the platform expands its global presence and strategic collaborations across the oncology and life sciences communities.
Jo brings more than three decades of experience across oncology clinical practice, research and development, clinical operations, and Global Medical Affairs. He joins OncoDaily with an extensive background in scientific alliances, commercial strategy, and international pharmaceutical partnerships.
Jo’s experience in partnership-building includes leading global scientific partnerships, managing large-scale industry alliances, and developing collaborations with major medical societies, research organizations, and healthcare stakeholders. He carried out this work in senior leadership positions at AstraZeneca and Novartis.
In his new executive role, Jo will lead OncoDaily’s global commercial strategy team. The team will focus on building multi-year strategic alliances across the pharmaceutical, biotechnology, diagnostics, and contract research organization (CRO) sectors. His work will support the expansion of OncoDaily’s international footprint, strengthen its industry relationships, and create new opportunities to connect innovation with the global oncology community.
About Jo Sawyer
Based in Basel, Switzerland, Jo Sawyer is an experienced oncology and pharmaceutical industry executive with more than 30 years of leadership experience across clinical practice, pharmaceutical research, clinical development, medical affairs, and strategic partnerships.
Throughout his career, he has worked at the intersection of scientific innovation, healthcare collaboration, and organizational leadership, developing partnerships that connect pharmaceutical companies with scientific societies, healthcare professionals, and research institutions.
Most recently, Sawyer served as Head of Global Scientific Partnerships & Global Medical Ethics for the Oncology Business Unit at AstraZeneca.
His work included helping establish AstraZeneca’s CHORUS and COSMOS collaboration platforms as part of developing and implementing global scientific partnership strategies. He played a leading role in this work.
He also directed international teams across multiple countries and led external scientific engagement with major professional medical societies, including the American Society of Clinical Oncology (ASCO) and the European Society for Medical Oncology (ESMO).
His responsibilities combined global scientific engagement, medical ethics, strategic alliance development, and cross-functional leadership, providing extensive experience in navigating complex partnerships within the international oncology landscape.
Before joining AstraZeneca, Jo held several senior leadership positions at other pharma companies, including Global Scientific Alliances Lead in Oncology Global Medical Affairs and Global Head of External Relationship Management.
Together, these roles have provided Jo with extensive experience in building long-term relationships between pharmaceutical companies, scientific organizations, clinical research networks, and other stakeholders involved in advancing cancer research and healthcare innovation.
His appointment brings this combination of scientific, operational, and commercial expertise to OncoDaily as the platform continues to expand its global oncology network.
Strengthening OncoDaily’s Global Industry Partnerships
Jo joins OncoDaily at a time when the platform is expanding its international reach, scientific initiatives, educational activities, and collaborations across the oncology ecosystem.
As Vice President of Strategic Partnerships and Industry Relations, he will lead efforts to establish and strengthen long-term strategic alliances with pharmaceutical and biotechnology companies, diagnostic organizations, CROs, scientific societies, and other healthcare stakeholders.
A central focus of his role will be developing sustainable partnerships across OncoDaily’s multi-channel media and educational ecosystem. These partnerships will bring together industry stakeholders, scientific leaders, researchers, healthcare professionals, and patient advocacy communities to engage with oncology professionals through scientific content, expert discussions, educational initiatives, and international events.
His appointment also reflects OncoDaily’s broader strategy of developing partnerships that extend beyond traditional media engagement, supporting scientific exchange, professional education, clinical evidence generation, and multidisciplinary collaboration.
For Jo, joining OncoDaily is an opportunity to help connect the international oncology community by applying his extensive experience in scientific alliances and global industry relations.
“I look forward to bringing my experience in scientific alliances and industry relations to OncoDaily. This role is an opportunity to build sustainable partnerships that connect industry, scientific leaders, healthcare professionals, and patient advocacy communities through scientific exchange and education,” said Jo Sawyer.